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Introduction. This special issue focuses on the role of complementary and alternative medicine (CAM) in cardiovascular
diseases (CVD). The role of CAM in healthcare specifically
in cardiovascular diseases (CVDs) has been a contentious
issue for centuries. With demographic shifts, urbanization,
and changing lifestyles, disease burden of cardiovascular
diseases (CVDs) has increased dramatically and can further
increase in the future. Despite the growing popularity of
CAM therapies, limited information is available regarding
patterns of use of CAM therapies in cardiovascular diseases.
The definition of CAM has continued to evolve. As
defined by the National Center of complementary and
alternative medicine (NCCAM), “it is a group of diverse
medical and healthcare systems, practices, and products that
are not generally considered part of conventional medicine.”
The 5 domains of CAM as classified by the NCCAM are
whole medical systems (e.g., homeopathy, and ayurvedic
medicine), mind-body interventions (e.g., yoga, meditation,
and hypnotherapy), biologically based therapies (e.g., herbal
treatments, mega-dose vitamins), manipulative and bodybased methods (e.g., chiropractic therapy), and energy therapies (e.g., Reiki, and magnetic therapy).
Over the last several decades, the use of CAM has become
increasingly popular in both developed and the developing
countries. A high proportion of patients using CAM believe
CAM has remedial benefits and are safe compared to their
prescribed treatments; this serves as a strong motivational
factor for both present and future use of CAM. In addition,

patients with CVD might be more likely to seek CAM treatments to decrease the psychological stress associated with
this condition. Misconceptions regarding their efficacy have
largely driven the popularity of these products whereas the
adverse effects have been underreported. In disadvantaged
societies where access to biomedical services is poor, the
reliance on traditional/herbal medicines is more. In affluent
population CAM is more used for disease prevention and
health promotion. Data from the National Health Interview
Surveys (NHIS) reported that 38% of adults in the USA were
using CAM therapy in 2007 and among those 36% had CVD.
CVD patients are often unwilling to inform their medical
practitioners of CAM use and the majority of attending
physicians do not discuss CAM use with their patients. Since
many commonly used CAM products have the potential to
interfere with the intended action of concomitant prescription medications, this could lead to serious drug interactions.
In addition, the use of CAM may have negative impact on the
compliance with prescription medications.
A number of CAM therapies have purported cardiovascular effects; but most research on these products is
either inconclusive, conflicting, or shows no benefit for their
use. Several systematic reviews and meta-analysis on the
effectiveness and possible side effects of CAM interventions
suggest that some approaches may be beneficial as adjuncts
to conventional management of cardiovascular disease, but
no evidence exists to support their role as primary treatment.
Dietary supplements (fish oil, coenzyme Q10, garlic, etc.)
are among the most commonly used treatment modalities in
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patients with CVD. Fish oil supplements are accepted as a part
of the treatment regimen for elevated serum triglycerides and
the maintenance of vascular wall health. However, the efficacy
of vitamin E has been questionable.
Another intervention of CAM, that is, mind-body therapies (relaxation, stress management, meditation, etc.) have
minimal side effects. However, in some countries unavailability of trained professionals in the field poses hindrance
in its usage. Several styles of meditation have been tested
and found to reduce blood pressure, improve heart rate,
and even provide survival benefit. Evidence-based trials have
been supportive of the conclusion that yoga can lower blood
pressure and improve physical fitness.
This one issue cannot answer all the questions regarding
the safety, efficacy, and effectiveness of CAM therapies in
CVDs. However, the main purpose of this issue is to open
the communication line between patients and physicians on
CAM use. It also illustrates the necessity of more rigorous
researches to determine the precise pharmacological effects
and long-term benefits on cardiovascular morbidity and
mortality with CAM usage.
Altogether, 27 papers were submitted for publication,
out of which 19 papers were accepted. The articles in this
issue represent a wide range of therapeutic approaches of
CAM in preventing cardiovascular diseases. There are papers
on extracts of herbal plants such as Nigella sativa, extract
of black chokeberry, Salvia miltiorrhiza, polyphenol and
Pueraria lobata, and their cardioprotective role in treating
hypertension. Ethanolic extract of black chokeberry fruits has
a potential role as prophylactic agent but can also function
as a nutritional supplement in the management of arterial
hypertension. In addition, a study on the use of repeatedly
heated oil (a common practice in Asian countries) concluded
that it has the predisposing factor of atherosclerosis leading
to cardiovascular diseases. Therefore, it is advisable to avoid
the consumption of repeatedly heated palm oil.
This special issue also has a number of reviews on the role
of CAM in preventing CVD. There is a review on the role of
garlic in cardiovascular diseases: treatment and prevention
which concluded that garlic can be used as an adjuvant
with lipid lowering drugs for control of lipids. Moreover,
another evidence-based review discusses CAM and CVDs;
this review recommends that more rigorous researches are
needed to determine the precise physiologic effects and longterm benefits on cardiovascular morbidity and mortality
with CAM usage. In addition, there is a review on Chinese
herbal medications (CHM) for hypertension. This review
on 10 systematic reviews found that the majority of the
RCTs (randomised controlled trials) do not include primary
endpoints and therefore their conclusions remain uncertain.
Another review on a traditional Chinese herbal formula,
Zhen Gan Xi Feng Decoction, appears to be effective in
improving blood pressure and symptoms in patients with
essential hypertension.
The edition also includes a paper on protein kinase II
signal transduction pathway that inhibits cardiac arrhythmia
in rats with myocardial infarction. Another study on palm
tocotrienol-rich fraction found that it was comparable to
folate in reducing high-methionine diet-induced plasma
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hyperhomocysteinemia, aortic oxidative stress, and inflammatory changes in rats.
Conclusion. The articles presented in this issue represent the
recognition of CAM’s role in CVD patients. Nevertheless,
better education of patients and medical practitioners is
needed to improve the understanding of the risks and benefits
of CAM use in CVD patients. Further pieces of evidence
are required to determine the impacts of CAM use in
CVD patients, particularly its clinical and prognostic impact
when used in conjunction with prescription medicines. An
open dialogue between healthcare professionals and patients
regarding intended or present CAM use is also warranted.
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